Ignite Creation Date:
2025-12-25 @ 2:44 AM
Ignite Modification Date:
2026-05-01 @ 8:03 AM
Study NCT ID:
NCT06048133
Status:
RECRUITING
Last Update Posted:
2025-05-04
First Post:
2023-09-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)
Sponsor:
Organization: